Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Chinese Medical Sciences Journal ; (4): 241-245, 2009.
Article in English | WPRIM | ID: wpr-299471

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the expression of programmed cell death 5 (PDCD5) in tissues of normal human prostate (NP), benign prostatic hyperplasia (BPH), and prostate cancer (PCa) in order to assess the clinical role of PDCD5 in PCa.</p><p><b>METHODS</b>PDCD5 expression was determined by EnVision immunohistochemical staining in formalin-fixed and paraffin-embedded specimens obtained from 12 subjects with NP, 22 with BPH, and 22 with PCa. In addition, PCa cases were classified as low/middle-risk (Gleason sum < or = 7) and high-risk (Gleason sum >7) on the basis of Gleason grade. Positive expression rates and intensity of PDCD5 protein were observed under light microscope and analyzed with computer imaging technique. Expression of PDCD5 was compared among different prostatic tissues.</p><p><b>RESULTS</b>The expression of PDCD5 was significantly lower in tissue of PCa than in tissues of NP and BPH (P<0.01). However, there was no significant difference in PDCD5 expression between tissues of NP and BPH. In addition, the expression of PDCD5 was further downregulated with the increase of Gleason sum in PCa.</p><p><b>CONCLUSIONS</b>By downregulating apoptosis, low PDCD5 expression may play an important role in the occurrence and development of PCa. PDCD5 is supposed to have a potential clinical value to be a new predictor of progression and target of gene therapy in PCa.</p>


Subject(s)
Aged , Humans , Male , Middle Aged , Apoptosis , Apoptosis Regulatory Proteins , Physiology , Immunohistochemistry , Neoplasm Proteins , Physiology , Prostate , Chemistry , Prostatic Neoplasms , Chemistry , Pathology , Proto-Oncogene Proteins c-bcl-2
2.
Journal of Southern Medical University ; (12): 750-753, 2008.
Article in Chinese | WPRIM | ID: wpr-280104

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the cell-killing effect of adenovirus-mediated TK-ganciclovir (GCV) gene therapy in combination with tumor necrosis factor-alpha (TNF-alpha) against murine bladder carcinoma cells in vitro.</p><p><b>METHODS</b>Murine bladder carcinoma MB49 cells were transfected with the adenoviral vector containing TK gene and green fluorescent protein (GFP) gene. The transfection efficiency was observed and the TK gene expression in the transfected cells was detected by RT-PCR. The survival rate of MB49 cells in response to TNF-alpha treatment and that of the TK gene-transfected cells after treatment with GCV and GCV+TNF-alpha were determined by MTT assay. The apoptosis of the cells after the treatments was analyzed by flow cytometry.</p><p><b>RESULTS</b>In cells transfected with TK gene, the cell inhibition rate increased gradually with the increment of GCV and TNF-alpha concentration. GCV in combination with TNF-alpha resulted in significantly increased killing efficiency of the cells as compared with GCV or TNF-alpha treatment alone, and the effect of the combined treatment was enhanced as the TNF-alpha concentration increased. GCV treatment (50 microg/ml) alone produced a cell killing rate of (24.39-/+1.10)%, and when combined with 5 microg/ml TNF-alpha, the rate was increased to (40.05-/+0.97) %, and further to (65.47-/+0.67) % when TNF-alpha concentration increased to 20 microg/ml. Flow cytometry revealed obvious apoptosis of the cells 8 h after treatments with TK/GCV, TNF-alpha, or TK/GCV+TNF-alpha, and the combined treatment resulted in the highest cell apoptotic rate.</p><p><b>CONCLUSION</b>TK/GCV in combination with TNF-alpha can enhance the effect of suicide gene therapy against murine bladder carcinoma cells and effectively induce apoptosis of the cells.</p>


Subject(s)
Animals , Mice , Adenoviridae , Genetics , Antiviral Agents , Pharmacology , Cell Line, Tumor , Cell Survival , Ganciclovir , Metabolism , Pharmacology , Genetic Therapy , Methods , Green Fluorescent Proteins , Genetics , Metabolism , Reverse Transcriptase Polymerase Chain Reaction , Thymidine Kinase , Genetics , Metabolism , Transfection , Tumor Necrosis Factor-alpha , Pharmacology , Urinary Bladder Neoplasms , Genetics , Metabolism , Pathology
3.
Journal of Southern Medical University ; (12): 1316-1318, 2006.
Article in Chinese | WPRIM | ID: wpr-334933

ABSTRACT

<p><b>OBJECTIVE</b>To study the role of programmed cell death 5 (PDCD5) protein in the oncogenesis and development of renal clear cell carcinoma and its association with the prognosis of the malignancy.</p><p><b>METHODS</b>PDCD5 expression was assayed immunohistochemically in 46 cases of human renal clear cell carcinoma, and the patients' survival was followed up.</p><p><b>RESULTS</b>PDCD5 staining in the adjacent normal tissue of the tumor was significantly stronger than that in the tumor tissue, and PDCD5 expression was significantly correlated with the tumor grade, stage and prognosis. The tumors of high grade with strong invasive ability had much less PDCD5 expression and lighter staining. The three- or five-year survival rates of patients positive for PDCD5 expression was much higher than that of patients negative for PDCD5 expression.</p><p><b>CONCLUSION</b>PDCD5 is a potent inhibitor of malignant transformation of renal clear cell carcinoma and may serve as a major predictor for evaluating the malignant potential and prognosis of the tumor.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Apoptosis Regulatory Proteins , Carcinoma, Renal Cell , Metabolism , Pathology , Immunohistochemistry , Kidney Neoplasms , Metabolism , Pathology , Neoplasm Proteins , Prognosis , Retrospective Studies , Survival Analysis
4.
Chinese Journal of Urology ; (12)2000.
Article in Chinese | WPRIM | ID: wpr-675953

ABSTRACT

Objective To discuss prevention and treatment of the late complications of deteniaceacal-colon continent urinary reservoir. Methods 105 patients who underwent detenia ceacal-colon con-tinent urinary reservoir were followed up for 9 -82 months(mean 40.5 months).Clinical data of these wereretrospectively analyzed. Results Late complications occurred in 25.7%(27/105) of the cases and 9were treated with operations,including difficulty with catheterization in 4 cases(3.8%),3 treated with dila-tion and 1 with efferent limb reconstruction with ileal,urinary pouch stones in 5(4.8%),4 treated with li-thotomy,urinary pouch perfotation in 1 (0.95%),treated with repair,urinary pouch superdistention in 1(0.95%),treated with reduction, single or double lateral hydronephrosis in 8(7.6%),caused by strictureof single or double lateral lower ureters in 4 (2 treated with excision lesion and anastomosis ) and by refluxin 1,1 case suffering from azotemia preoperatively worsened to uraemia treated with regular haemodialysis,hyperchloremia in 7 (6.7%),only 1 needed drugs treatment,repeated urinary infection in 11,amomg them,10 were complicated by the other complications,all treated with sensitive antibiotic. Conclusions Most ofpatients underwent detenia ceacal-colon continent urinary reservoir had good curative effects. Late complica-tions afflicting these patients mostly had immediate or mediate relations with symptomatic urinary infection.Prevention and treatment of symptomatic urinary infection can reduce the occurrence of late complications ofthis operative method,regular and adequant pouch washing and catheterization is efficient to prevention oflate complications of this operative method.

SELECTION OF CITATIONS
SEARCH DETAIL